Abstract:Various stresses, including pressure overload and myocardial stretch, can trigger cardiac remodeling and result in heart diseases. The disorders are associated with high risk of morbidity and mortality and are among the major health problems in the world. MicroRNAs, a class of ~22nt-long small non-coding RNAs, have been found to participate in regulating heart development and function. One of them, miR-208a, a cardiac-specific microRNA, plays key role(s) in modulating gene expression in the heart, and is involved in a broad array of processes in cardiac pathogenesis. Genetic deletion or pharmacological inhibition of miR-208a in rodents attenuated stress-induced cardiac hypertrophy and remodeling. Transgenic expression of miR-208a in the heart was sufficient to cause hypertrophic growth of cardiomyocytes. miR-208a is also a key regulator of cardiac conduction system, either deletion or transgenic expression of miR-208a disturbed heart electrophysiology and could induce arrhythmias. In addition, miR-208a appeared to assist in regulating the expression of fast- and slow-twitch myofiber genes in the heart. Notably, this heart-specific miRNA could also modulate the “endocrine” function of cardiac muscle and govern the systemic energy homeostasis in the whole body. Despite of the critical roles, the underlying regulatory networks involving miR-208a are still elusive. Here, we summarize the progress made in understanding the function and mechanisms of this important miRNA in the heart, and propose several topics to be resolved as well as the hypothetical answers. We speculate that miR-208a may play diverse and even opposite roles by being involved in distinct molecular networks depending on the contexts. A deeper understanding of the precise mechanisms of its action under the conditions of cardiac homeostasis and diseases is needed. The clinical implications of miR-208a are also discussed.

Advances of microRNAs in pathological myocardial hypertrophy

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

The Role of MicroRNA in Myocardial Remodeling

Role of microRNA in process of acute myocardial infarction

The Effects of MicroRNAs in the Development of Heart Failure

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

MicroRNAs and therapeutic potentials in acute and chronic cardiac disease

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

MicroRNAs: novel regulators in cardiac development and disease

Recent progress on microRNA in diagnosis and treatment of myocardial infarction

Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

miR-208a in Cardiac Hypertrophy and Remodeling

mir15a/mir16‐1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

MicroRNA-1 in Cardiac Diseases and Cancers.

MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1

MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte Hypertrophy